Pregnant women at risk of preeclampsia. Eclampsia in pregnancy
Conditions
Interventions
Intervention 1: Intervention group: Pregnant mothers before 10 weeks who entered the study received 80 mg of aspirin daily. Intervention 2: Control group: pregnant mothers receive 80 mg of aspirin dai
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Pregnant women who are at risk of preeclampsia People with underlying vascular diseases People with chronic hypertension People with diabetes People with a history of preeclampsia
Exclusion criteria
Exclusion criteria: People with asthma diseases People with NSAID allergy People with peptic ulcer People with bleeding disorders People with nasal polyps
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of preeclampsia. Timepoint: end of pregnancy. Method of measurement: blood pressure and proteinuria.;The type of delivery. Timepoint: During childbirth. Method of measurement: Vaginal or Caesarian.;Baby's weight. Timepoint: During childbirth. Method of measurement: Digital scale.;Consequences of pregnancy. Timepoint: During pregnancy and childbirth. Method of measurement: Recorded by the researcher.;Post partum hemorrhage. Timepoint: During childbirth. Method of measurement: Recorded by the researcher.;Infant's APGAR score. Timepoint: after childbirth. Method of measurement: APGAR criteria.;Pregnancy outcome. Timepoint: During childbirth. Method of measurement: Frequency of live births/still births/neonatal abnormalities. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTaraneh Arbabzadeh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed